Patent 11753463 was granted and assigned to Orionis Biosciences on September, 2023 by the United States Patent and Trademark Office.
The present invention relates, in part, to chimeric proteins that bind a non-cellular structure and their use as therapeutic agents. The present invention further relates to pharmaceutical compositions comprising the chimeric proteins and their use in the treatment of various diseases.